Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (9395)	3/28/1999 8:52:00 PM
From: Cacaito	Respond to of 17367

home.miningco.com everything about miningcocom.

To: Cacaito who wrote (9395)	3/28/1999 10:02:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Cacaito, forget the accruals! Ellen said focus on just the mortality. Murphy was focused on his 125, which was really 130. I was just as wrong!! I was focused on the 200. These numbers don't drive the process. The deaths alone will determine the accruals, not the accruals determining the deaths. Apparently one can determine statistical significance just using deaths in the treatment and placebo groups. But, I don't know how. BTW miningco was a new issue on Tuesday?? I tried it out for meningococemia and did not find it very helpful. Perhaps I need to learn how to use it better. The concept is interesting, in that in theory a real specialist gets involved at some point in making the search more effective.